SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2008 Biotech Stock Picking for Charity -- Ignore unavailable to you. Want to Upgrade?


To: BulbaMan who wrote (148)3/20/2008 5:20:17 PM
From: BulbaMan  Read Replies (1) | Respond to of 322
 
3/20/08 update
It's an especially good Good Friday this year for dizzy investors needing an extra day of rest to recover from the stock market's wild gyrations. When the closing bell finally rang on Thursday and the manic bulls & bears moved to their corners for a three-day rest, the Nasdaq Composite Index was down -14.86% YTD (doing a bit better than the -16.58% YTD loss a week ago).
The Nasdaq Biotech Index and the Contest portfolios both also finished the week higher. At Thursday's close, the NBI was down -10.77% YTD (vs. -11.39% YTD a week ago), while the median of the Contest portfolios closed off -13.64% YTD (vs. -17.35% YTD a week ago).
At Friday's close, there were still just two of the 33 Contest portfolios in the black YTD with 14 of the portfolios beating the NBI. ROBERT's portfolio remained in first place with a 20.8% YTD gain with RCMAC's portfolio moving into second place with a 0.3% YTD gain. (My own portfolio, in second place last Friday, was DVAXed to 15th place.)
Have a great three-day weekend folks!
Below is the Top Ten list on 3/20/08:

3/20/08
Rank Name Total
1 ROBERT 20,767
2 RCMAC 264
3 ROBO -1,832
4 HAMMER -2,385
5 BIOFISH -4,963
6 LJM -6,972
7 GENE -7,101
8 FRED -7,204
9 CASA -7,502
10 ROCKY9 -8,102

(All corrections, especially adjustments for splits, greatly appreciated.)



To: BulbaMan who wrote (148)3/25/2008 4:51:53 PM
From: technetium  Read Replies (3) | Respond to of 322
 
Bulba, I enjoy reading your writing. Well crafted words take away the sting from the throw the baby out with the bathwater approach on Wall Street lately.

Biotechs won't get a Bear Stearns bailout, and this is a bad time to raise money for speculative investments when so many blue chips look cheap and risky. (And biotechs always need money, unless they're among the few that are profitable.)

As to my biotech portfolio, can we get a red-green color blind judge to pick the winners this year? :-)